Dr. Reddy's Laboratories Limited RDY
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -14.48% | -16.40% | -1.00% | 5.39% | 8.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.48% | -16.40% | -1.00% | 5.39% | 8.57% |
| Cost of Revenue | 6.13% | 3.80% | 11.10% | 18.21% | 18.15% |
| Gross Profit | -30.10% | -32.56% | -9.52% | -3.31% | 2.28% |
| SG&A Expenses | 1.75% | 9.18% | 5.83% | 10.24% | 10.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 44.56% | 53.10% | -30.02% | -28.16% | -67.63% |
| Total Operating Expenses | 2.99% | 3.39% | 6.60% | 10.91% | 12.60% |
| Operating Income | -82.26% | -93.68% | -27.37% | -13.64% | -4.69% |
| Income Before Tax | -73.73% | -90.61% | -21.94% | -8.14% | -1.35% |
| Income Tax Expenses | -78.46% | -104.84% | -28.78% | -31.93% | -1.53% |
| Earnings from Continuing Operations | -72.07% | -86.86% | -19.65% | 2.05% | -1.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.93% | -105.73% | 101.62% | 111.58% | -- |
| Net Income | -71.68% | -86.94% | -18.83% | 9.86% | -0.71% |
| EBIT | -82.26% | -93.68% | -27.37% | -13.64% | -4.69% |
| EBITDA | -64.22% | -76.95% | -20.90% | -7.22% | -0.02% |
| EPS Basic | -71.72% | -86.92% | -18.77% | 9.89% | -0.65% |
| Normalized Basic EPS | -79.30% | -91.34% | -20.39% | -5.68% | 0.62% |
| EPS Diluted | -71.69% | -86.91% | -18.70% | 9.96% | -0.60% |
| Normalized Diluted EPS | -79.27% | -91.33% | -20.36% | -5.50% | 0.68% |
| Average Basic Shares Outstanding | 0.19% | 0.06% | -0.08% | -0.04% | -0.06% |
| Average Diluted Shares Outstanding | 0.08% | -0.04% | -0.13% | -0.11% | -0.12% |
| Dividend Per Share | -- | -5.41% | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -0.13% | -- |